Literature DB >> 24566711

Apoptotic signaling through Fas and TNF receptors ameliorates GVHD in mobilized peripheral blood grafts.

K Mizrahi1, I Yaniv2, S Ash2, J Stein3, N Askenasy1.   

Abstract

Mobilized peripheral blood (mPB) is a prevalent source of hematopoietic progenitors for transplantation; however, allogeneic and haploidentical transplants are often accompanied by severe GVHD. Following the observation that murine GVHD is ameliorated by pretransplant donor cell exposure to Fas-ligand (FasL) without host-specific sensitization, we assessed the susceptibility of mPB cells to spontaneous and receptor-induced apoptosis as a possible approach to GVHD prophylaxis. Short incubation for 4 h resulted in spontaneous apoptosis of 50% of the T and B lymphocytes and 60% myeloid cells. Although expression of Fas and TNF-R1 was proportionate to fractional apoptosis, cell death was dominated by spontaneous apoptosis. Functional assays revealed that the death receptors modulated mPB graft composition as compared with incubation in medium, without detectable quantitative variations. Removal of dead cells increased the frequency of mPB myeloid progenitors (P<0.001 vs medium), and recipients of mPB exposed to death ligands displayed reduced GVHD (P<0.01 vs medium) and improved survival following lipopolysacharide stimulation. mPB grafts exposed to the apoptotic challenge retained SCID reconstituting potential and graft versus tumor activity. These data emphasize that short-term exposure of mPB grafts to an apoptotic challenge is effective in reduction of GVHD effector activity.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24566711     DOI: 10.1038/bmt.2014.12

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  60 in total

1.  Regulatory functions of TRAIL in hematopoietic progenitors: human umbilical cord blood and murine bone marrow transplantation.

Authors:  K Mizrahi; J Stein; M Pearl-Yafe; O Kaplan; I Yaniv; N Askenasy
Journal:  Leukemia       Date:  2010-05-20       Impact factor: 11.528

Review 2.  Transplantation of autologous peripheral blood progenitor cells: impact of CD34-cell selection on immunological reconstitution.

Authors:  S Rutella; L Pierelli; S Sica; C Rumi; G Leone
Journal:  Leuk Lymphoma       Date:  2001 Nov-Dec

3.  Quantitative analysis of Fas and bcl-2 expression in hematopoietic precursors.

Authors:  L Maurillo; G Del Poeta; A Venditti; F Buccisano; A Battaglia; S Santinelli; T Caravita; A M Epiceno; B Del Moro; A Tamburini; A Picardi; G Suppo; G Catalano; A Bruno; S Amadori
Journal:  Haematologica       Date:  2001-03       Impact factor: 9.941

Review 4.  Graft-versus-host disease.

Authors:  Warren D Shlomchik
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

5.  Ex vivo anti-CD3 antibody-activated donor T cells have a reduced ability to cause lethal murine graft-versus-host disease but retain their ability to facilitate alloengraftment.

Authors:  W R Drobyski; D Majewski; K Ozker; G Hanson
Journal:  J Immunol       Date:  1998-09-01       Impact factor: 5.422

6.  Hematopoietic transplants for disease suppression and cure in type 1 diabetes.

Authors:  Nadir Askenasy
Journal:  Curr Stem Cell Res Ther       Date:  2013-07       Impact factor: 3.828

7.  Long-lasting skin allograft tolerance in adult mice induced across fully allogeneic (multimajor H-2 plus multiminor histocompatibility) antigen barriers by a tolerance-inducing method using cyclophosphamide.

Authors:  H Mayumi; R A Good
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

8.  TNF-α has tropic rather than apoptotic activity in human hematopoietic progenitors: involvement of TNF receptor-1 and caspase-8.

Authors:  Keren Mizrahi; Jerry Stein; Isaac Yaniv; Offer Kaplan; Nadir Askenasy
Journal:  Stem Cells       Date:  2013-01       Impact factor: 6.277

9.  Humanized anti-CD25 monoclonal antibody for prophylaxis of graft-vs-host disease (GVHD) in haploidentical bone marrow transplantation without ex vivo T-cell depletion.

Authors:  Hui-Ren Chen; Shu-Quan Ji; Heng-Xiang Wang; Hong-Ming Yan; Ling Zhu; Jing Liu; Mei Xue; Chang-Qing Xun
Journal:  Exp Hematol       Date:  2003-11       Impact factor: 3.084

10.  Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation.

Authors:  Wayne R Godfrey; Mark R Krampf; Patricia A Taylor; Bruce R Blazar
Journal:  Blood       Date:  2003-10-02       Impact factor: 22.113

View more
  10 in total

Review 1.  Death-defining immune responses after apoptosis.

Authors:  L Campisi; R J Cummings; J Magarian Blander
Journal:  Am J Transplant       Date:  2014-06-05       Impact factor: 8.086

2.  Serum from Acute-on-chronic Liver Failure Patients May Affect Mesenchymal Stem Cells Transplantation by Impairing the Immunosuppressive Function of Cells.

Authors:  Yongyuan Zheng; Shu Zhu; Xingrong Zheng; Wenxiong Xu; Xuejun Li; Jianguo Li; Zhiliang Gao; Chan Xie; Liang Peng
Journal:  J Clin Transl Hepatol       Date:  2021-03-30

3.  Negative selection by apoptosis enriches progenitors in naïve and expanded human umbilical cord blood grafts.

Authors:  K Mizrahi; S Ash; T Peled; I Yaniv; J Stein; N Askenasy
Journal:  Bone Marrow Transplant       Date:  2014-04-28       Impact factor: 5.483

Review 4.  Antigen-Specific Priming is Dispensable in Depletion of Apoptosis-Sensitive T Cells for GvHD Prophylaxis.

Authors:  Shai Yarkoni; Jerry Stein; Isaac Yaniv; Nadir Askenasy
Journal:  Front Immunol       Date:  2014-05-19       Impact factor: 7.561

Review 5.  Exploiting Cell Death Pathways for Inducible Cell Elimination to Modulate Graft-versus-Host-Disease.

Authors:  Corey Falcon; Mustafa Al-Obaidi; Antonio Di Stasi
Journal:  Biomedicines       Date:  2017-06-14

6.  Anti-IL-22 Antibody Attenuates Acute Graft-versus-Host Disease via Increasing Foxp3+ T Cell through Modulation of CD11b+ Cell Function.

Authors:  Jianbo Wu; Jian Gu; Shun Zhou; Hao Lu; Yunjie Lu; Ling Lu; Xuehao Wang
Journal:  J Immunol Res       Date:  2018-08-07       Impact factor: 4.818

Review 7.  Cytotoxic Pathways in Allogeneic Hematopoietic Cell Transplantation.

Authors:  Wei Du; Xuefang Cao
Journal:  Front Immunol       Date:  2018-12-19       Impact factor: 7.561

8.  Treatment with Mesenchymal Stromal Cells Overexpressing Fas-Ligand Ameliorates Acute Graft-versus-Host Disease in Mice.

Authors:  Andrei Mircea Vacaru; Ana-Maria Mazilu; Madalina Dumitrescu; Ioana Madalina Fenyo; Anca Violeta Gafencu; Ana-Maria Vacaru
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

Review 9.  Mesenchymal Stromal Cells for Graft Versus Host Disease: Mechanism-Based Biomarkers.

Authors:  Tik Shing Cheung; Giuliana Minani Bertolino; Chiara Giacomini; Martin Bornhäuser; Francesco Dazzi; Antonio Galleu
Journal:  Front Immunol       Date:  2020-06-25       Impact factor: 7.561

10.  A DL-4- and TNFα-based culture system to generate high numbers of nonmodified or genetically modified immunotherapeutic human T-lymphoid progenitors.

Authors:  Ranjita Devi Moirangthem; Kuiying Ma; Sabrina Lizot; Anne Cordesse; Juliette Olivré; Corinne de Chappedelaine; Akshay Joshi; Agata Cieslak; John Tchen; Nicolas Cagnard; Vahid Asnafi; Antonio Rausell; Laura Simons; Julien Zuber; Tom Taghon; Frank J T Staal; Françoise Pflumio; Emmanuelle Six; Marina Cavazzana; Chantal Lagresle-Peyrou; Tayebeh Soheili; Isabelle André
Journal:  Cell Mol Immunol       Date:  2021-06-11       Impact factor: 11.530

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.